Hoff, Fieke W. http://orcid.org/0000-0002-7128-1255
Banerjee, Rahul http://orcid.org/0000-0003-3781-5441
Khan, Adeel M. http://orcid.org/0000-0002-9462-6316
McCaughan, Georgia
Wang, Bo
Wang, Xiaoliang
Roose, James http://orcid.org/0000-0002-4442-1742
Anderson, Larry D. Jr. http://orcid.org/0000-0002-6531-9595
Cowan, Andrew J.
Rajkumar, S. Vincent http://orcid.org/0000-0002-5862-1833
Kaur, Gurbakhash http://orcid.org/0000-0002-2510-6536
Article History
Received: 11 November 2023
Revised: 29 February 2024
Accepted: 7 March 2024
First Online: 22 March 2024
Competing interests
: RB: Consulting: BMS, Caribou Biosciences, Genentech, Janssen, Karyopharm, Pfizer, Sanofi, SparkCures; Research: Pack Health. XW: Employment: Flatiron Health, Inc. (independent subsidiary of the Roche Group), stock ownership, Roche. JR: Employment: Flatiron Health, Inc. (independent subsidiary of the Roche Group), stock ownership, Roche. LDA Jr: Consulting: Janssen, Celgene, BMS, Amgen, GSK, AbbVie, Beigene, Cellectar, Sanofi, Prothena. Research: BMS, Celgene, GSK, Janssen, Abbvie. AJC: Consulting: BMS, Adaptive; Research: Adaptive Biotechnologies, Harpoon, Nektar, BMS, Janssen, Sanofi, AbbVie. GK: Consulting: BMS, Arcellx, Sanofi, Janssen, Cellectar, Pfizer, Kedrion; Research: BMS, Janssen, Abbvie. The remaining authors have no disclosures to report.